HomeCompareMXROF vs JNJ

MXROF vs JNJ: Dividend Comparison 2026

MXROF yields 800.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MXROF wins by $2773896.43M in total portfolio value
10 years
MXROF
MXROF
● Live price
800.00%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2773896.46M
Annual income
$2,226,430,694,490.38
Full MXROF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — MXROF vs JNJ

📍 MXROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMXROFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MXROF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MXROF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MXROF
Annual income on $10K today (after 15% tax)
$68,000.00/yr
After 10yr DRIP, annual income (after tax)
$1,892,466,090,316.82/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, MXROF beats the other by $1,892,466,086,279.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MXROF + JNJ for your $10,000?

MXROF: 50%JNJ: 50%
100% JNJ50/50100% MXROF
Portfolio after 10yr
$1386948.25M
Annual income
$1,113,215,349,620.13/yr
Blended yield
80.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MXROF
No analyst data
Altman Z
-4.3
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MXROF buys
0
JNJ buys
0
No recent congressional trades found for MXROF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMXROFJNJ
Forward yield800.00%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$2773896.46M$30.5K
Annual income after 10y$2,226,430,694,490.38$4,749.88
Total dividends collected$2730603.49M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MXROF vs JNJ ($10,000, DRIP)

YearMXROF PortfolioMXROF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$90,700$80,000.00$10,594$274.49+$80.1KMXROF
2$775,180$678,130.84$11,294$360.69+$763.9KMXROF
3$6,246,019$5,416,576.76$12,133$476.91+$6.23MMXROF
4$47,472,138$40,788,897.61$13,156$635.42+$47.46MMXROF
5$340,525,323$289,730,135.14$14,432$854.61+$340.51MMXROF
6$2,306,680,888$1,942,318,792.24$16,056$1,162.76+$2306.66MMXROF
7$14,764,459,529$12,296,310,979.28$18,175$1,604.53+$14764.44MMXROF
8$89,354,478,583$73,556,506,887.09$21,009$2,252.68+$89354.46MMXROF
9$511,650,252,638$416,040,960,553.41$24,911$3,229.73+$511650.23MMXROF
10$2,773,896,464,813$2,226,430,694,490.38$30,458$4,749.88+$2773896.43MMXROF

MXROF vs JNJ: Complete Analysis 2026

MXROFStock

Max Resource Corp. engages in the acquisition, exploration, and development of mineral properties. The company holds interest in the Cesar copper-silver project situated in Colombia. It also has an option to acquire a 100% interest in the RT Gold property that includes two contiguous mineral concessions located within the district of Tabaconas, Peru. The company was formerly known as Vancan Capital Corp. and changed its name to Max Resource Corp. in May 2004. Max Resource Corp. was incorporated in 1994 and is headquartered in Vancouver, Canada.

Full MXROF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MXROF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MXROF vs SCHDMXROF vs JEPIMXROF vs OMXROF vs KOMXROF vs MAINMXROF vs ABBVMXROF vs MRKMXROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.